Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Qian-Yun Lin"'
Autor:
Mingsong Li, Le Liu, Hongwei Zhou, Ye Chen, Gary D. Wu, Yunsheng Yang, Yuqiang Nie, Anupriya Tripathi, Qian-Yun Lin, Amnon Amir, Minhu Chen, Zhenjiang Zech Xu, Side Liu, Youlian Zhou, Yan He, Rob Knight, Antonio Gonzalez, Fachao Zhi
Publikováno v:
mSystems, Vol 3, Iss 1 (2018)
mSystems, vol 3, iss 1
Zhou, Y; Xu, ZZ; He, Y; Yang, Y; Liu, L; Lin, Q; et al.(2018). Gut microbiota offers universal biomarkers across ethnicity in inflammatory bowel disease diagnosis and infliximab response prediction. mSystems, 3(1). doi: 10.1128/mSystems.00188-17. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/0ht2v5sc
mSystems, Vol 3, Iss 1, p e00188-17 (2018)
mSystems
mSystems, vol 3, iss 1
Zhou, Y; Xu, ZZ; He, Y; Yang, Y; Liu, L; Lin, Q; et al.(2018). Gut microbiota offers universal biomarkers across ethnicity in inflammatory bowel disease diagnosis and infliximab response prediction. mSystems, 3(1). doi: 10.1128/mSystems.00188-17. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/0ht2v5sc
mSystems, Vol 3, Iss 1, p e00188-17 (2018)
mSystems
In the present report, we show that the human fecal microbiota contains promising and universal biomarkers for the noninvasive evaluation of inflammatory bowel disease severity and IFX treatment efficacy, emphasizing the potential ability to mine the
Autor:
Jing Nie, Hanchang He, Dan Lv, Pu Wang, Qian-Yun Lin, Hongwei Zhou, Fan Fan Hou, Shuanghong Jiang, Jianping Jiang, Youlian Zhou, Shan Xie, Ting Zhang, Ye Chen
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
Scientific Reports
Scientific Reports
We evaluated differences in the compositions of faecal microbiota between 52 end stage renal disease (ESRD) patients and 60 healthy controls in southern China using quantitative real-time polymerase chain reaction (qPCR) and high-throughput sequencin
Autor:
Pu Wang, Shuanghong Jiang, Yan Zhang, Ye Chen, Ting Zhang, Jia-Xi Fei, Minyi Lin, Qian-Yun Lin
Publikováno v:
Scientific Reports
The prevalence of Clostridium difficile infection (CDI) in patients suffering from inflammatory bowel disease (IBD) has increased rapidly over the past several decades in North America and Europe. However, the exact global epidemiology remains unclea
Autor:
Qian-Yun Lin, Shuanghong Jiang, Ye Chen, Jia-Xi Fei, Pu Wang, Minyi Lin, Yan Zhang, Ting Zhang
Publikováno v:
Scientific Reports. 6
The prevalence of Clostridium difficile infection (CDI) in patients suffering from inflammatory bowel disease (IBD) has increased rapidly over the past several decades in North America and Europe. However, the exact global epidemiology remains unclea